An updated meta-analysis incorporating nine randomized trials (n= 816) investigating low-to-
moderate dose prolonged glucocorticoid treatment in acute respiratory distress syndrome …

Purpose To investigate the effect of prolonged glucocorticoid treatment for patients with
acute respiratory distress syndrome (ARDS). Methods We conducted two sets of intention-to …

ABSTRACT INTRODUCTION Acute respiratory distress syndrome (ARDS) is a rapidly
progressing, inflammatory lung disease with a high mortality rate and no specific …

Objective: Controversy remains as to whether low-dose corticosteroids can reduce the
mortality and morbidity of acute lung injury (ALI) or the acute respiratory distress syndrome …

Objectives To compare the design and results of randomized trials investigating prolonged
glucocorticoid treatment (≥ 7 days) in patients with acute lung injury–acute respiratory …

The aim of this study was to describe the role of glucocorticoids in immune modulation
during critical illness and to review clinical trials and recent meta-analyses of glucocorticoids …

BACKGROUND: Randomized trials investigating the effect of corticosteroids in the treatment
of acute lung injury, acute respiratory distress syndrome, and severe pneumonia have had …

Introduction The effectiveness of corticosteroid therapy on the mortality of acute respiratory
distress syndrome (ARDS) remains under debate. We aimed to explore the grounds for the …

Background: Evidence exploring the use of corticosteroids for acute respiratory distress
syndrome (ARDS) has targeted various stages of disease progression, from preventing …

The acute respiratory distress syndrome (ARDS) is a common and vexing problem faced by
critical care providers worldwide. Despite extensive investigation over the past 3 decades …